(E)-2-(4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride

Catalog No. :
ACLNDP594
CAS No. :
51529-01-2
Molecular Formula :
C23H27Cl2F3N2OS
Molecular Weight :
507.45

IUPAC Name:(E)-2-(4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride

(E)-2-(4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-2-(4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride
IUPAC Name(E)-2-(4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride
Molecular FormulaC23H27Cl2F3N2OS
Molecular Weight507.45
SMILESCl.Cl.OCCN1CCN(CC/C=C2\C3=CC=CC=C3SC3=C2C=C(C(F)(F)F)C=C3)CC1
InChI KeyIOVDQEIIMOZNNA-MONHGIHASA-N
SynonymFlupenthixol 2HCl;Flupenthixol 2hydrochloride;cis-Flupenthixol (hydrochloride);(Z)-Flupenthixol dihydrochloride;CIS-(Z)-FLUPENTHIXOL DIHYDROCHLORIDE ANT IPSYCHOTIC, NEUROL;4-[3-[(3Z)-2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Hydrochloride;cis (Z)-Flupentixol Dihydrochloride;cis-Flupentixol Hydrochloride
CAS No.51529-01-2

Synthetic Route by SureRoute

1. ACLNDP594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNDP594 route product structure diagram
    ACLNDP59451529-01-2
Inquiry

2. ACLNDP594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLNDP594 route product structure diagram
    ACLNDP59451529-01-2
Inquiry

Comments (0)